685 related articles for article (PubMed ID: 34366264)
1. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
2. Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study.
Anike O; Zhang Q; Bhasin S; Flanders WD; Getahun D; Haw JS; Huybrechts KF; Lash TL; McCracken CE; Roblin D; Silverberg MJ; Suglia SF; Tangpricha V; Vupputuri S; Goodman M
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38815002
[TBL] [Abstract][Full Text] [Related]
3. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy.
Antun A; Zhang Q; Bhasin S; Bradlyn A; Flanders WD; Getahun D; Lash TL; Nash R; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Endocr Soc; 2020 Nov; 4(11):bvaa119. PubMed ID: 33834151
[TBL] [Abstract][Full Text] [Related]
5. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
[TBL] [Abstract][Full Text] [Related]
6. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
7. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
8. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
9. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
11. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
13. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
14. Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data From the STRONG Cohort.
Islam N; Nash R; Zhang Q; Panagiotakopoulos L; Daley T; Bhasin S; Getahun D; Sonya Haw J; McCracken C; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1549-e1557. PubMed ID: 34850912
[TBL] [Abstract][Full Text] [Related]
15. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
[TBL] [Abstract][Full Text] [Related]
16. Gender minority stress in transgender people: a major role for social network.
Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
[TBL] [Abstract][Full Text] [Related]
17. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
[TBL] [Abstract][Full Text] [Related]
18. Influence of sex hormone use on sleep architecture in a transgender cohort.
Morssinkhof MWL; van der Werf YD; van den Heuvel OA; van den Ende DA; van der Tuuk K; den Heijer M; Broekman BFP
Sleep; 2023 Nov; 46(11):. PubMed ID: 37715990
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
